Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Organigram Holdings Inc. - Common Shares (NQ: OGI )

1.323 -0.037 (-2.72%)
Streaming Delayed Price Updated: 2:44 PM EST, Feb 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 640,887
Open 1.360
Bid (Size) 1.320 (15)
Ask (Size) 1.330 (127)
Prev. Close 1.360
Today's Range 1.300 - 1.360
52wk Range 1.270 - 2.910
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Cannabis Stock Movers For February 17, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
Organigram (OGI) Q1 2025 Earnings Call Transcript
OGI earnings call for the period ending December 31, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial

Performance

YTD
-20.30%
-20.30%
1 Month
-14.09%
-14.09%
3 Month
-8.76%
-8.76%
6 Month
-31.09%
-31.09%
1 Year
-36.09%
-36.09%

More News

Read More
Cannabis Producer Organigram Q1 Sales Jump 17%, Expect C$10 Million From Motif Integration, Annual Run-Rate Synergies Within Two Years
Via Benzinga
Topics Cannabis
Exposures Cannabis
Organigram Reports First Quarter Fiscal 2025 Results
From Organigram Holdings Inc.
Via Business Wire
OrganiGram Holdings Earnings Review: Q4 Summary
Via Benzinga
OrganiGram Holdings Q4 Earnings Assessment
Via Benzinga
Earnings Scheduled For February 11, 2025
Via Benzinga
Organigram to Report First Quarter Fiscal 2025 Results on February 11, 2025
From Organigram Holdings Inc.
Via Business Wire
DEA Accused Of Bias In Cannabis Rescheduling Hearings: Weed Stocks Plummeted In 2024 As Process Drags On
Via Benzinga
Topics Cannabis
Exposures Cannabis
Bullish Wednesday For Marijuana Stocks - Cara Therapeutics, MPX International Among Top Gainers
Via Benzinga
Topics Cannabis
Exposures Cannabis
Organigram Reports Fourth Quarter and Fiscal 2024 Results
From Organigram Holdings Inc.
Via Business Wire
Organigram (OGI) Q4 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Cannabis Player Organigram Clocks Q4 Gross Margin Of 37% On Higher Efficiency Across Cultivation And Higher Recreational Sales, Stock Soars
Via Benzinga
Topics Cannabis
Exposures Cannabis
Earnings Scheduled For December 18, 2024
Via Benzinga
Organigram to Report Fourth Quarter and Fiscal 2024 Results on December 18, 2024
From Organigram Holdings Inc.
Via Business Wire
Organigram Wants To Become Canada's Largest Cannabis Company By Market Share Via $71M Acquisition Deal
Via Benzinga
Topics Cannabis
Exposures Cannabis
Organigram Acquires Motif, Becoming Canada’s Largest Cannabis Company by Market Share
From Organigram Holdings Inc.
Via Business Wire
Are You Missing Out On This NASDAQ-Listed Weed Stock? Low-Cost Model Meets European Demand
Via Benzinga
Topics Cannabis
Exposures Cannabis
Decibel Cannabis: One Acquisition Could Be The Key To Unlocking $20M In Cash Flow
Via Benzinga
Topics Cannabis
Exposures Cannabis
Organigram Launches FAST™ Nanoemulsion Gummies
From Organigram Holdings Inc.
Via Business Wire
Cannabis Stocks Pop Following Chris Christie's Prediction That Trump Will Deschedule Cannabis
Via Benzinga
Topics Cannabis Government
Exposures Cannabis Political
Cannabis Stocks Collapse After Trump Win: Major Players See Double-Digit Declines At Wednesday's Close
Via Benzinga
Topics Cannabis Government
Exposures Cannabis Political
Canada's Cannabis Market Goes Cold, Pot Prices Hit Bottom: Why Top Producers Are Losing Ground
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stocks Rally: Canopy, Aurora, SNDL, OrganiGram And Others See Gains
Via Benzinga
Topics Cannabis
Exposures Cannabis
How Germany's Cannabis Market Is Dominating Europe And Unlocking New Profit Opportunities
Via Benzinga
Topics Cannabis
Exposures Cannabis
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.